Your browser doesn't support javascript.
loading
Pain management in patients with malignant mesothelioma: challenges and solutions.
Saunders, J; Ashton, M; Hall, C; Laird, B; MacLeod, N.
Afiliação
  • Saunders J; Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, UK, Jocelyn.saunders@hotmail.co.uk.
  • Ashton M; Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, UK, Jocelyn.saunders@hotmail.co.uk.
  • Hall C; Institute of Cancer Sciences, University of Glasgow, UK.
  • Laird B; Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XR, UK.
  • MacLeod N; St Columba's Hospice, Edinburgh EH5 3RW, UK.
Lung Cancer (Auckl) ; 10: 37-46, 2019.
Article em En | MEDLINE | ID: mdl-31037036
Malignant pleural mesothelioma (MPM) is an aggressive cancer with a considerable symptom burden and poor prognosis. Focus on maintaining patients' quality of life and pain control is therefore paramount. Pain management in MPM is complex due to its multifactorial etiology resulting from direct tumor infiltration of the surrounding soft tissue, bone, and encasement of the intercostal nerves. A variety of treatment modalities, including pharmacological and non-pharmacological options, are often required to achieve adequate pain control in this challenging disease. This review article examines the current challenges and solutions available for pain management in MPM.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article